Expression of c-Met in Primary and Recurrent Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Oncology"
DOI: 10.1159/000504806
Abstract: Background:The clinical course of hepatocellular carcinoma (HCC) is complicated, because it often recurs and shows multiple lesions, some of which progress to a more malignant form, shortening the life of the patient. The hepatocyte growth… read more here.
Keywords: hepatocellular carcinoma; primary recurrent; expression met; hcc ... See more keywords
Immunohistochemical Expression of “c-MET” in Breast Carcinomas
Sign Up to like & getrecommendations! Published in 2020 at "Open Access Macedonian Journal of Medical Sciences"
DOI: 10.3889/oamjms.2020.5070
Abstract: BACKGROUND: Targeted therapies achieved great success in managing breast cancer, however, triple negative breast cancers (TNBCs) lack the expression of traditional therapeutic targets, and other subtypes develop resistance to current therapies. The c-MET receptor emerged… read more here.
Keywords: expression met; patient selection; breast; clinical trials ... See more keywords